BCL2 and hepatocellular carcinoma: In addition, overexpression of miR-383 significantly decreased Bcl-2 expression in cancer cells.43 Moreover, miR-383 could inhibit cell growth and induce cell apoptosis in hepatocellular carcinoma cells.